Literature DB >> 8902713

Transcriptional activation by the androgen receptor in X-linked spinal and bulbar muscular atrophy.

H Nakajima1, F Kimura, T Nakagawa, D Furutama, K Shinoda, A Shimizu, N Ohsawa.   

Abstract

Polyglutamine tracts encoded by trinucleotide CAG repeats have been found in some transcription factors. Expansion of the polyglutamine tracts in the androgen receptor (AR) has been recognized as a cause of X-linked spinal and bulbar muscular atrophy (SBMA). To study the role of AR as a transcription factor in SBMA, we constructed AR genes encoding expanded polyglutamine tracts (repeat numbers = 52, 92, 132, and 212), and analyzed AR-induced transcriptional activation in NG108-15 cells. We found that AR-induced transcriptional activation gradually decreased with increasing glutamine repeat numbers, and polyglutamine expansion caused a specific reduction in transcription activity in motor neurons. However, the degree of reduction was slight in comparison with the normal AR gene and that of SBMA. Thus, subtle disorders of transcriptional control may occur in SBMA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8902713     DOI: 10.1016/0022-510x(96)00142-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia.

Authors:  Axel M Hillmer; Sandra Hanneken; Sibylle Ritzmann; Tim Becker; Jan Freudenberg; Felix F Brockschmidt; Antonia Flaquer; Yun Freudenberg-Hua; Rami Abou Jamra; Christine Metzen; Uwe Heyn; Nadine Schweiger; Regina C Betz; Bettina Blaumeiser; Jochen Hampe; Stefan Schreiber; Thomas G Schulze; Hans Christian Hennies; Johannes Schumacher; Peter Propping; Thomas Ruzicka; Sven Cichon; Thomas F Wienker; Roland Kruse; Markus M Nothen
Journal:  Am J Hum Genet       Date:  2005-05-18       Impact factor: 11.025

2.  Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamine.

Authors:  S Iuchi; G Hoffner; P Verbeke; P Djian; H Green
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

Review 3.  Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Andrew P Lieberman
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

Review 4.  Reflections on the diseases linked to mutations of the androgen receptor.

Authors:  Angelo Poletti; Paola Negri-Cesi; Luciano Martini
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.925

5.  The polyglutamine-expanded androgen receptor has increased DNA binding and reduced transcriptional activity.

Authors:  Sergey Belikov; Laura C Bott; Kenneth H Fischbeck; Örjan Wrange
Journal:  Biochem Biophys Rep       Date:  2015-07-26

Review 6.  Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease.

Authors:  Frederick J Arnold; Diane E Merry
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.